I think this will be an overreaction and the shareprice will certainly bounce from this. The science holds, and Orphan Drug Status is almost a given from the companies I've witnessed in the past.
This month will see a nice earn from those investing or topping up now. Remember there are many others in the company getting the trials to where they are now, and everyone is replaceable. ODD next month will be a nice reminder to everyone about this
Ann: Resignation of Dr Michael Thurn & appointment of John Clark, page-81
-
- There are more pages in this discussion • 181 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |